Global Analysis from the European Perspective. Preparing for the world of tomorrow

France, Poland, Sweden latest EU countries to rule out AstraZeneca jab for elderly

France, Poland and Sweden on Tuesday issued recommendations not to use the COVID-19 vaccine developed by AstraZeneca for the elderly. They join Germany and Italy which issued such recommendations last week. Authorities in France and Sweden say the vaccine should be prioritised for people under the age of 65, both citing insufficient clinical trial data for older people. Source EuroNews

GEFIRA provides in-depth and comprehensive analysis of and valuable insight into current events that investors, financial planners and politicians need to know to anticipate the world of tomorrow; it is intended for professional and non-professional readers.

Yearly subscription: 10 issues for €225/$250
Renewal: €160/$175

The Gefira bulletin is available in ENGLISH, GERMAN and SPANISH.